K. Dong, G. Wang, Z. L. Wang, and X. Wang, “Efficacy and safety of regorafenib versus dinutuximab with chemotherapy in Chinese children with neuroblastoma”, Bangladesh J Pharmacol, vol. 14, no. 1, pp. 32–35, Feb. 2019.